The Future of Regenerative Peptide Therapy The field of peptide therapy continues to evolve as more research becomes available
4.3 Liver and kidney surgeries (ischemiareperfusion injury and immune modulation) 4.3.1 Liver surgery/transplantation The liver is rich in macrophages (Kupffer cells) and is often subject to IR during inflow occlusion in resection or during transplant graft implantation
This segment is led by a duopoly: Novo Nordisk's semaglutide (Ozempic for diabetes, Wegovy for obesity) and Eli Lilly's tirzepatide (Mounjaro for T2D, Zepbound for obesity and sleep apnea) together commanded 57.4% of the overall peptide therapy market in 2026 an extraordinary concentration in a USD 84.2 billion market
The reality of peptide therapy, whether it is Sermorelin, CJC-1295, Ipamorelin, or BPC-157, is that it is not a light switch
Particularly those people whove been freckled their whole life
This stabilization is usually through intramolecular hydrogen bonding and delocalization or by reaction with other lipid radicals and further oxidation